Microbot Medical Inc. (MBOT)

Microbot Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.15	3.91	3.11	2.47	2.44	13.49
Short-Term Investments	64.22	74.68	2.36	3.92	5.76	2
Cash & Short-Term Investments	67.37	78.59	5.47	6.39	8.21	15.49
Cash Growth	106.18%	1336.78%	-14.33%	-22.18%	-47.04%	-37.15%
Other Receivables	-	0.24	0.09	1.4	0.1	0.17
Receivables	0.18	0.24	0.09	1.4	0.1	0.17
Inventory	2.91	0.58	-	-	-	-
Prepaid Expenses	0.71	0.4	0.21	0.09	0.43	0.13
Restricted Cash	0.2	0	0.05	0.05	0.08	0.09
Other Current Assets	0.81	-	-	-	-	-
Total Current Assets	72.17	79.82	5.82	7.92	8.81	15.88
Property, Plant & Equipment	1.12	0.93	0.21	0.41	0.72	0.89
Other Long-Term Assets	0.08	0.8	-	-	-	-
Total Assets	73.37	81.54	6.03	8.33	9.54	16.77

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.87	0.51	0.17	0.36	0.12	0.28
Accrued Expenses	2.69	2.52	2.22	1.03	1.67	1.43
Current Portion of Leases	0.33	0.3	0.07	0.19	0.28	0.28
Current Unearned Revenue	-	0.09	-	-	-	-
Other Current Liabilities	-	0.01	0.01	2.21	-	-
Total Current Liabilities	3.89	3.42	2.46	3.79	2.07	1.98
Long-Term Leases	0.55	0.57	0.04	0.04	0.18	0.4
Total Liabilities	4.44	3.99	2.5	3.83	2.25	2.39

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.67	0.67	0.2	0.12	0.08	0.07
Additional Paid-In Capital	181.64	180.97	94.28	83.88	75.97	69.9
Retained Earnings	-113.38	-104.09	-90.94	-79.5	-68.76	-55.59
Shareholders' Equity	68.93	77.55	3.53	4.5	7.29	14.38
Total Liabilities & Equity	73.37	81.54	6.03	8.33	9.54	16.77

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.88	0.87	0.11	0.23	0.46	0.68
Net Cash (Debt)	66.49	77.73	5.36	6.15	7.74	14.81
Net Cash Growth	104.43%	1350.40%	-12.92%	-20.52%	-47.73%	-37.86%
Net Cash Per Share	1.06	1.70	0.34	0.60	1.07	2.08
Filing Date Shares Outstanding	67.16	67.16	34.74	14.4	8.13	7.11
Total Common Shares Outstanding	67.16	67.16	19.4	11.71	7.89	7.11
Working Capital	68.29	76.4	3.36	4.14	6.75	13.9
Book Value Per Share	1.03	1.15	0.18	0.38	0.92	2.02
Tangible Book Value	68.93	77.55	3.53	4.5	7.29	14.38
Tangible Book Value Per Share	1.03	1.15	0.18	0.38	0.92	2.02
Machinery	-	0.5	0.44	0.41	0.38	0.3
Leasehold Improvements	-	0.23	0.23	0.23	0.23	0.23

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error